Baron Wealth Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
PCM
AAM
WCMNY
PWAM
Baron Wealth Management's AMED Position: Q3 2023 in Review
Baron Wealth Management sold out of Amedisys (AMED) in Q3 2023, closing a stake of 2,822 shares — an estimated $258K sold.
Baron Wealth Management first reported a position in AMED in Q4 2022 and held it in 3 quarters. The position peaked at $258K in Q2 2023. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.
- Baron Wealth Management reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
- Baron Wealth Management sold 2,822 Amedisys shares in Q3 2023, an estimated $258K.
- Baron Wealth Management first reported a position in Amedisys in Q4 2022 and held it in 3 quarters.
- Baron Wealth Management's Amedisys position peaked at $258K in Q2 2023.
- 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.
Based on Baron Wealth Management's 13F filing for Q3 2023, filed 1 Nov 2023.